The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
Current issues in ER and HER2 testing by IHC in breast cancer
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., et al. (1989) · Science · doi:10.1126/science.2470152 · Cited by 6,816
Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
Romond, E. H., Perez, E. A., Bryant, J., Suman, V. J., Geyer, C. E., Davidson, N. E., Tan-Chiu, E., Martino, S., Paik, S., Kaufman, P. A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052122 · Cited by 5,356
Trastuzumab after Adjuvant Chemotherapy in HER2-Positive Breast Cancer
Piccart-Gebhart, M. J., Procter, M., Leyland-Jones, B., Goldhirsch, A., Untch, M., Smith, I., Gianni, L., Baselga, J., Bell, R., Jackisch, C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052306 · Cited by 5,084
Wolff, A. C., Hammond, M. E. H., Schwartz, J. N., Hagerty, K. L., Allred, D. C., Cote, R. J., Dowsett, M., Fitzgibbons, P. L., Hanna, W. M., Langer, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.2775 · Cited by 4,434
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
Geyer, C. E., Forster, J., Lindquist, D., Chan, S., Romieu, C. G., Pienkowski, T., Jagiello-Gruszfeld, A., Crown, J., Chan, A., Kaufman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa064320 · Cited by 3,425
Cobleigh, M. A., Vogel, C. L., Tripathy, D., Robert, N. J., Scholl, S., Fehrenbacher, L., Wolter, J. M., Paton, V., Shak, S., Lieberman, G., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2639 · Cited by 2,765
Prognostic and predictive factors in breast cancer by immunohistochemical analysis.
Allred, D. C., Harvey, J. M., Berardo, M. D., & Gm, C. (1998) · PubMed · Cited by 2,143
Harvey, J. M., Clark, G. M., Osborne, C. K., & Allred, D. C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1474 · Cited by 2,056
Vogel, C. L., Cobleigh, M. A., Tripathy, D., Gutheil, J. C., Harris, L. N., Fehrenbacher, L., Slamon, D. J., Murphy, M., Novotny, W. F., Burchmore, M., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.3.719 · Cited by 1,860
Wolff, A. C., Hammond, M. E. H., Schwartz, J. N., Hagerty, K. L., Allred, D. C., Cote, R. J., Dowsett, M., Fitzgibbons, P. L., Hanna, W. M., Langer, A., et al. (2007) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2007-131-18-asocco · Cited by 1,816
Prognostic Factors in Breast Cancer: College of American Pathologists Consensus Statement 1999
Fitzgibbons, P. L., Page, D. L., Weaver, D., Thor, A. D., Allred, D. C., Clark, G. M., Ruby, S. G., O'Malley, F., Simpson, J. F., Connolly, J. L., et al. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-0966-pfibc · Cited by 1,016
Press, M. F., Bernstein, L., Thomas, P. A., Meisner, L. F., Zhou, J. Y., Ma, Y., Hung, G., Robinson, R. A., Harris, C., El-Naggar, A., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.8.2894 · Cited by 802
Bardou, V.-J., Arpino, G., Elledge, R. M., Osborne, C. K., & Clark, G. M. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.099 · Cited by 752
The value of estrogen and progesterone receptors in the treatment of breast cancer
Osborne, C. K., Yochmowitz, M. G., Knight, W. A., & McGuire, W. L. (1980) · Cancer · doi:10.1002/1097-0142(19801215)46:12+<2884::aid-cncr2820461429>3.0.co;2-u · Cited by 720
Pauletti, G., Dandekar, S., Rong, H., Ramos, L., Peng, H., Seshadri, R., & Slamon, D. J. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.21.3651 · Cited by 670
erbB-2, p53, and Efficacy of Adjuvant Therapy in Lymph Node-Positive Breast Cancer
Thor, A. D., Berry, D. A., Budman, D. R., Muss, H. B., Kute, T., Henderson, I. C., Barcos, M., Cirrincione, C., Edgerton, S., Allred, C., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1346 · Cited by 612
Paik, S., Hazan, R., Fisher, E. R., Sass, R. E., Fisher, B., Redmond, C., Schlessinger, J., Lippman, M. E., & King, C. R. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.1.103 · Cited by 594
Anderson, W. F., Chatterjee, N., Ershler, W. B., & Brawley, O. W. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1020299707510 · Cited by 585
HER-2/neu oncogene protein and prognosis in breast cancer.
Tandon, A. K., Clark, G. M., Chamness, G. C., Ullrich, A., & McGuire, W. L. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.8.1120 · Cited by 574
(1996) · PubMed · Cited by 554
HER2 and Responsiveness of Breast Cancer to Adjuvant Chemotherapy
Pritchard, K. I., Shepherd, L. E., O'Malley, F. P., Andrulis, I. L., Tu, D., Bramwell, V. H., & Levine, M. N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054504 · Cited by 509
Paik, S., Bryant, J., Tan-Chiu, E., Romond, E., Hiller, W., Park, K., Brown, A., Yothers, G., Anderson, S., Smith, R., et al. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.11.852 · Cited by 484
Press, M. F., Hung, G., Godolphin, W. J., & Slamon, D. (1994) · PubMed · Cited by 478
Jacobs, T. W., Gown, A. M., Yaziji, H., Barnes, M. J., & Schnitt, S. J. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.7.1983 · Cited by 457
Self-citationHER-2 Testing in Breast Cancer Using Parallel Tissue-Based Methods
Yaziji, H. (2004) · JAMA · doi:10.1001/jama.291.16.1972 · Cited by 438
Perez, E. A., Suman, V. J., Davidson, N. E., Martino, S., Kaufman, P. A., Lingle, W. L., Flynn, P. J., Ingle, J. N., Visscher, D., & Jenkins, R. B. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.4744 · Cited by 438
Immunohistochemistry of Estrogen and Progesterone Receptors Reconsidered
Nadji, M., Gomez-Fernandez, C., Ganjei-Azar, P., & Morales, A. R. (2005) · American Journal of Clinical Pathology · doi:10.1309/4wv7-9n2g-hj3x-1841 · Cited by 426
Baselga, J., Carbonell, X., Castañeda-Soto, N.-J., Clemens, M., Green, M., Harvey, V., Morales, S., Barton, C., & Ghahramani, P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.014 · Cited by 425
Press, M. F., Slamon, D. J., Flom, K. J., Park, J., Zhou, J.-Y., & Bernstein, L. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.094 · Cited by 391
Concordance Between Local and Central Laboratory HER2 Testing in the Breast Intergroup Trial N9831
Roche, P. C., Suman, V. J., Jenkins, R. B., Davidson, N. E., Martino, S., Kaufman, P. A., Addo, F. K., Murphy, B., Ingle, J. N., & Perez, E. A. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.11.855 · Cited by 390
Estrogen receptor β: Potential functional significance of a variety of mRNA isoforms
Lewandowski, S., Kalita, K., & Kaczmarek, L. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03015-6 · Cited by 374
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer
(2007) · New England Journal of Medicine · doi:10.1056/nejmx070016 · Cited by 350
De Laurentiis, M., Arpino, G., Massarelli, E., Ruggiero, A., Carlomagno, C., Ciardiello, F., Tortora, G., D'Agostino, D., Caputo, F., Cancello, G., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2569 · Cited by 340
Lebeau, A., Deimling, D., Kaltz, C., Sendelhofert, A., Iff, A., Luthardt, B., Untch, M., & Löhrs, U. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.354 · Cited by 326
Press, M. F., Sauter, G., Bernstein, L., Villalobos, I. E., Mirlacher, M., Zhou, J.-Y., Wardeh, R., Li, Y.-T., Guzman, R., Ma, Y., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0636 · Cited by 311
Lehr, H.-A., Mankoff, D. A., Corwin, D., Santeusanio, G., & Gown, A. M. (1997) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549704501112 · Cited by 308
Self-citationJacobs, T. W., Gown, A. M., Yaziji, H., Barnes, M. J., & Schnitt, S. J. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.7.1974 · Cited by 302
Self-citationLeyland-Jones, B., Gelmon, K., Ayoub, J.-P., Arnold, A., Verma, S., Dias, R., & Ghahramani, P. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.109 · Cited by 293
Mohsin, S. K., Weiss, H., Havighurst, T., Clark, G. M., Berardo, M., Roanh, L. D., To, T. V., Zho, Q., Love, R. R., & Allred, D. C. (2004) · Modern Pathology · doi:10.1038/modpathol.3800229 · Cited by 290
Goldstein, M., Ferkowicz, M., Odish, H., Mani, M., & Hastah, M. (2003) · American Journal of Clinical Pathology · doi:10.1309/qphd-rb00-qxgm-uq9n · Cited by 280
Rationale for trastuzumab (Herceptin) in adjuvant breast cancer trials
SLAMON, D. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90188-5 · Cited by 243
Barnes, D., Harris, W., Smith, P., Millis, R., & Rubens, R. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.563 · Cited by 241
HER-2 Testing and Trastuzumab Therapy for Metastatic Breast Cancer: A Cost-Effectiveness Analysis
Elkin, E. B., Weinstein, M. C., Winer, E. P., Kuntz, K. M., Schnitt, S. J., & Weeks, J. C. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.158 · Cited by 230
Dybdal, N., Leiberman, G., Anderson, S., McCune, B., Bajamonde, A., Cohen, R. L., Mass, R. D., Sanders, C., & Press, M. F. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-6275-8 · Cited by 216
Cheang, M. C. U., Treaba, D. O., Speers, C. H., Olivotto, I. A., Bajdik, C. D., Chia, S. K., Goldstein, L. C., Gelmon, K. A., Huntsman, D., Gilks, C. B., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.4155 · Cited by 206
Self-citationGong, Y., Yan, K., Lin, F., Anderson, K., Sotiriou, C., Andre, F., Holmes, F. A., Valero, V., Booser, D., Pippen, J. E., et al. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70042-6 · Cited by 195
The Evaluation of Estrogen Receptor in Primary Breast Carcinoma by Computer-Assisted Image Analysis
Bacus, S., Flowers, J. L., Press, M. F., Bacus, J. W., & Mccarty, K. S. (1988) · American Journal of Clinical Pathology · doi:10.1093/ajcp/90.3.233 · Cited by 193
Collins, L. C., Botero, M. L., & Schnitt, S. J. (2005) · American Journal of Clinical Pathology · doi:10.1309/hcf0-35n9-wk40-etj0 · Cited by 178
Ménard, S., Valagussa, P., Pilotti, S., Gianni, L., Biganzoli, E. M., Boracchi, P., Tomasic, G., Casalini, P., Marubini, E., COLNAGHI, M. I., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.329 · Cited by 149
Increased HER2 With U.S. Food and Drug Administration-Approved Antibody
Roche, P. C., & Ingle, J. N. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.434 · Cited by 147
Pertschuk, L. P., Feldman, J. G., Kim, Y.-D., Braithwaite, L., Schneider, F., Braverman, A. S., & Axiotis, C. A. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960615)77:12<2514::aid-cncr14>3.0.co;2-v · Cited by 133
Varshney, D., Zhou, Y. Y., Geller, S. A., & Alsabeh, R. (2004) · American Journal of Clinical Pathology · doi:10.1309/fuqh-92b0-3902-5lhg · Cited by 112
Couturier, J., Vincent‐Salomon, A., Nicolas, A., Beuzeboc, P., Mouret, E., Sigal‐Zafrani, B., & Sastre‐Garau, X. (2000) · Modern Pathology · doi:10.1038/modpathol.3880228 · Cited by 111
Polysomy 17 in HER-2/neu Status Elaboration in Breast Cancer: Effect on Daily Practice
Ma, Y., Lespagnard, L., Durbecq, V., Paesmans, M., Desmedt, C., Gomez-Galdón, M., Veys, I., Cardoso, F., Sotiriou, C. P., Leo, A. D., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2256 · Cited by 108
Concordance Between Central and Local Laboratory HER2 Testing from a Community-Based Clinical Study
Reddy, J. C., Reimann, J. D., Anderson, S. M., & Klein, P. M. (2006) · Clinical Breast Cancer · doi:10.3816/cbc.2006.n.025 · Cited by 107
Enhanced Accuracy and Reliability of HER-2/neu Immunohistochemical Scoring Using Digital Microscopy
Bloom, K., & Harrington, D. S. (2004) · American Journal of Clinical Pathology · doi:10.1309/y73u-8x72-b68t-mgh5 · Cited by 106
Gown, A. M., Goldstein, L. C., Barry, T. S., Kussick, S. J., Kandalaft, P. L., Kim, P. M., & Tse, C. C. H. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.83 · Cited by 100
Self-citationCardoso, F., Durbecq, V., Larsimont, D., Paesmans, M., Leroy, J., Rouas, G., Sotiriou, C. P., Renard, N., Richard, V., Piccart, M. J., et al. (2004) · International Journal of Oncology · doi:10.3892/ijo.24.1.201 · Cited by 94
Hodi, Z., Chakrabarti, J., Lee, A. H. S., Ronan, J. E., Elston, C. W., Cheung, K., Robertson, J. F. R., & Ellis, I. O. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.036665 · Cited by 75
Objective measurement of breast cancer oestrogen receptor status through digital image analysis
Mofidi, R., Walsh, R., Ridgway, P. F., Crotty, T. B., McDermott, E. W. M., Keaveny, T. V., Duffy, M. J., Hill, A. D. K., & O’Higgins, N. J. (2003) · European Journal of Surgical Oncology · doi:10.1053/ejso.2002.1373 · Cited by 69
Tawfik, O. W., Kimler, B. F., Davis, M., Donahue, J. K., Persons, D. L., Fan, F., Hagemeister, S., THOMAS, P. A., Connor, C. S., Jewell, W. R., et al. (2005) · Histopathology · doi:10.1111/j.1365-2559.2005.02322.x · Cited by 68
Cited by
An overview of triple-negative breast cancer
Kumar, P., & Aggarwal, R. (2016) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3859-y · Cited by 771
Biosensors: the new wave in cancer diagnosis
Mousa, S. (2010) · Nanotechnology, Science and Applications · doi:10.2147/nsa.s13465 · Cited by 381
Nielsen, T., Wallden, B., Schaper, C., Ferree, S., Liu, S., Gao, D., Barry, G., Dowidar, N., Maysuria, M., & Storhoff, J. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-177 · Cited by 311
Protocol for the Examination of Specimens From Patients With Invasive Carcinoma of the Breast
Lester, S. C., Bose, S., Chen, Y.-Y., Connolly, J. L., de Baca, M. E., Fitzgibbons, P. L., Hayes, D. F., Kleer, C., O'Malley, F. P., Page, D. L., et al. (2009) · Archives of Pathology & Laboratory Medicine · doi:10.5858/133.10.1515 · Cited by 302
Triple negative breast cancers: Clinical and prognostic implications
Dawson, S. J., Provenzano, E., & Caldas, C. (2009) · European Journal of Cancer · doi:10.1016/s0959-8049(09)70013-9 · Cited by 266
Metadata
- Authors
- Gown, A. M.
- Venue
- Modern Pathology
- Publisher
- Elsevier BV
- Published
- 2008-05
- Volume
- 21
- Pages
- S8-S15
- ISSN
- 0893-3952 (ISSN-L)
- OpenAlex
- W2072228651
- Cited by
- 374
- References
- 61
- FWCI
- 14.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.